Pages that link to "Item:Q725696"
From MaRDI portal
The following pages link to Incoherent dose-escalation in phase I trials using the escalation with overdose control approach (Q725696):
Displaying 4 items.
- Incorporating a patient dichotomous characteristic in cancer phase I clinical trials using escalation with overdose control (Q454783) (← links)
- Escalation with overdose control using ordinal toxicity grades for cancer phase I clinical trials (Q1929691) (← links)
- Number of patients per cohort and sample size considerations using dose escalation with overdose control (Q1929695) (← links)
- A continual reassessment method without undue risk of toxicity (Q6171847) (← links)